Tan et al. revealed that TAMs expressed high levels of TREM2 in following transarterial chemoembolization (TACE), which played an important role in limiting the functions of CD8+ T cells and was associated with a worse clinical prognosis in hepatocellular carcinoma (HCC) [104]. This evidence concerns the gene CD8A and hepatocellular carcinoma.